Narcolepsy

Nursing Clinics of North America

Volumn 37, Issue 4, 2002, Pages 675-692

  Rogers, Ann E ^a   Dreher, H Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

BEHAVIOR THERAPY; CATAPLEXY; DIET THERAPY; HUMAN; METHODOLOGY; NARCOLEPSY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT EDUCATION; REVIEW;

BEHAVIOR THERAPY; CATAPLEXY; CENTRAL NERVOUS SYSTEM STIMULANTS; DIET THERAPY; HUMANS; NARCOLEPSY; PATIENT COMPLIANCE; PATIENT EDUCATION;

EID: 0036986102     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-6465(02)00035-X     Document Type: Review

References (93)

1. Olafsdottir B.R., Rye D.B., Scammell T.E., et al. Polymorphisms in hypocretin/orexin pathway genes and narcolepsy. Neurology 57 (2001) 1896-1899
2. National Commission on Sleep Disorders Research. Report of the National Commission on Sleep Disorders Research. DHHS Pub. No. 93-XXXX (1993), US Government Printing Office, Washington, DC
3. Nishino S., Okura M., and Mignot E. Narcolepsy: genetic predisposition and neuropharmacological mechanisms. Sleep Medicine Review 4 (2000) 57-59
4. Dauvilliers Y., Montplaisir J., Molinari N., et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 57 (2001) 2029-2033
5. Okun M.L., Lin L., Pelin Z., et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep 25 (2002) 27-35
6. Honda Y., Asaka A., Tanimura M., et al. A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy or hypersomnia proband. In: Guilleminault C., and Lugaresi E. (Eds). Sleep/wake disorders: natural history, epidemiology, and long-term evolution (1983), Raven Press, New York 188-199
7. Broughton W.A., and Broughton R.J. Psychosocial impact of narcolepsy. Sleep 17 (1994) S45-S47
8. Parkes J.D. Sleep and its disorders (1985), W.B. Saunders, London
9. Stepanski E., Lamphere J., Badiz P., et al. Sleep fragmentation and daytime sleepiness. Sleep 7 (1984) 18-26
10. Billiard M., Besset A., and Cadihac J. The clinical and polygraphic development of narcolepsy. In: Guilleminault C., and Lugaresi E. (Eds). Sleep/wake disorders: natural history, epidemiology, and long-term evolution (1983), Raven Press, New York 171-185
11. Broughton R.J. Narcolepsy. In: Thorpy M.J. (Ed). Handbook of sleep disorders (1990), Marcel Dekker, New York 197-216
12. Roy A. Psychiatric aspects of narcolepsy. Br J Psychiatry 128 (1976) 562-565
13. Broughton R., and Ghanem Q. The impact of compound narcolepsy on the life of the patient. In: Guilleminault C., Dement W.C., and Passouant P. (Eds). Narcolepsy: advances in sleep research vol. 3 (1976), Spectrum Publications, New York 201-220
14. Broughton R., Ghanem Q., Hishikawa Y., et al. Life effects of narcolepsy in 180 patients from North America, Asia, and Europe compared to matched controls. Can J Neurol Sci 8 (1981) 199-204
15. Passouant P., and Billiard M. The evolution of narcolepsy with age. In: Guilleminault C., Dement W.C., and Passouant P. (Eds). Narcolepsy: advances in sleep research vol. 3 (1976), Spectrum Publications, New York 179-196
16. Rogers A.E. Problems and coping strategies identified by narocleptic subjects. J Neurosurg Nurs 16 (1984) 326-334
17. McMahon B.T., Walsh J.K., Sexton K., et al. Need satisfaction in narcolepsy. Rehabil Lit 43 (1982) 82-85
18. Broughton R.J., Guberman A., and Roberts J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Epilepsia 25 (1984) 423-433
19. Buesterien K.M., Rogers A.E., Walsleben J.A., et al. Health-related quality of life effects of modafinil for the treatment of narcolepsy. Sleep 22 (1999) 757-767
20. Mitler M.M., and Gujavarty K.S. Narcolepsy: when to suspect it and how to help. Consultant 4 (1982) 215-224
21. Thorpy M.J., Snyder M., Aloe F.S., et al. Short-term triazolam use improves nocturnal sleep of narcoleptics. Sleep 15 (1992) 212-216
22. Rogers A.E., Aldrich M.S., and Caruso C.C. Patterns of sleep and wakefulness in treated narcoleptic subjects. Sleep 17 (1994) 590-597
23. International Food Council. IFIC review: caffeine and health. July 1998. Available at:. http://www.ific.org/proactive/newsroom/release.vtml?id=17784 Accessed January 29, 2002
24. Melberg A., Ripley B., Lin L., et al. Hypocretin deficiency in familial symptomatic narcolepsy. Ann Neurol 49 (2001) 136-137
25. Silber M.H., and Rye D.B. Solving the mysteries of narcolepsy: the hypocretin story. Neurology 56 (2001) 1616-1618
26. Dalal M.A., Schuld A., Haack M., et al. Normal plasma levels of orexin A (hypocretin-1) in narcoletic patients. Neurology 56 (2001) 1749-1750
27. Nishino S., Ripley B., Overeem S., et al. Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50 (2001) 381-388
28. Arii J., Kanbayashi T., Tanabe Y., et al. A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor. Neurology 56 (2001) 1775
29. Malik S., Boeve B.F., Krahn L.E., et al. Narcolepsy associated with other central nervous system disorders. Neurology 57 (2001) 539-541
30. Scammell T.E., Nishino S., Mignot E., et al. Narcolepsy and low CSF orexin (hypocretin) concentration after diencephalic stroke. Neurology 56 (2001) 1751-1753
31. Lin L., Faraco J., Li R., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (Orexin) receptor 2 gene. Cell 98 (1999) 365-376
32. Chemelli R.M., Willie J.T., Sinton C.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-457
33. Nishino S., Fujiki N., Sakurai E., et al. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett 313 (2001) 125-128
34. Honda Y., Takahaski Y., Honda M., et al. Genetic aspects of narcolepsy. In: Hayaishi O., and Inoue S. (Eds). Sleep and sleep disorders: from molecule to behavior (1997), Takeda Science Foundation, Tokyo 341-358
35. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 50 Suppl 1 (1998) S16-S22
36. Guilleminault C., Mignot E., and Grumet C. Family study of narcolepsy. Lancet 11 (1989) 1376-1380
37. Matsuki K., Honda Y., Satake M., et al. HLA in narcolepsy in Japan. In: Honda Y., and Juju T. (Eds). HLA in narcolepsy (1988), Springer-Verlag, Berlin 58-76
38. Montplaisir J., and Poirier G. HLA in narcolepsy in Canada. In: Honda Y., and Juju T. (Eds). HLA in narcolepsy (1988), Springer-Verlag, Berlin 97-107
39. Partinen M., Hublin C., Kaprio J., et al. Twin studies in narcolepsy. Sleep 17 (1994) S13-S16
40. Carlander B., Eliaou J.F., and Billiard M. Autoimmune hypothesis in narcolepsy. Neurophysiol Clin 23 (1993) 15-22
41. Mignot E., Tafti M., Dement W.C., et al. Narcolepsy and immunity. Adv Neuroimmunol 5 (1995) 23-37
42. Anch A.M., Browman C.P., Mitler M.M., et al. Sleep: a scientific perspective (1988), Prentice Hall, Englewood Cliffs, NJ
43. Roehrs R., Zorick F., Wittig R., et al. Alerting effects of naps in patients with narcolepsy. Sleep 9 (1986) 191-194
44. Mitler M.M., Aldrich M.S., Koob G.F., et al. Narcolepsy and its treatment with stimulants. Sleep 17 (1994) 352-371
45. Broughton R.J., Fleming J.A.E., George C.F.P., et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 49 (1997) 444-451
46. Fry J.M. Treatment modalities for narcolepsy. Neurology 50 Suppl 1 (1998) S43-S48
47. Nishino S., and Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 52 (1997) 27-28
48. US Modafinil in narcolepsy multicenter study group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 43 (1998) 88-97
49. Godbout R., and Montplaisir J. All-day performance variations in normal and narcoleptic subjects. Sleep 9 (1986) 200-204
50. Helmus T., Rosenthal L., Bishop C., et al. The alerting effects of short and long naps in narcoleptic, sleep-deprived, and alert individuals. Sleep 20 (1997) 251-257
51. Mullington J., and Broughton R. Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy. Sleep 16 (1993) 444-456
52. Rogers A.E., and Aldrich M.S. Do regularly scheduled naps reduce sleep attacks and excessive daytime sleepiness associated with narcolepsy?. Nurs Res 42 (1993) 111-117
53. Rogers A.E., Aldrich M.S., and Lin X. A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy. Sleep 24 (2001) 1-7
54. Yuchiyama M., Mayer G., and Meirer-Ewart K. Differential effects of extended sleep in narcoleptic patients. Electroencephalogr Clin Neurophysiol 91 (1994) 212-218
55. Montplaisir J., and Godbout R. Nocturnal sleep of narcoleptics: revisited. Sleep 9 (1986) 159-161
56. Scrima L., Hartman P.G., Johnson Jr. F.R., et al. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double blind subjective measures. Biol Psychiatry 26 (1985) 331-341
57. Garma L., and Marchand F. Non-pharmacological approaches to the treatment of narcolepsy. Sleep 17 (1994) S97-S102
58. Panetar D., McCann U., Kamimori G., et al. Caffeine reversal of sleep deprivation effects on alertness and mood. Psychopharmacology (Berlin) 112 (1993) 359-365
59. Wright Jr. K.P., Badia P., Myers B.L., et al. Combination of bright light and caffeine as a countermeasure for impaired alertness and performance during extended sleep deprivation. J Sleep Res 6 (1997) 26-35
60. Parkes J.D., and Dahlitz M. Amphetamine prescription. Sleep 16 (1993) 201-203
61. Thorpy M.J., and Goswami M. Treatment of narcolepsy. In: Thorpy M.J. (Ed). Handbook of sleep disorders (1990), Dekker, New York 235-258
62. Bell I.R. Diet history in narcolepsy. In: Guilleminault C., Dement W.C., and Passouant P. (Eds). Narcolepsy (1976), Spectrum, New York 221-228
63. Kales A., and Kales J. Sleep disorders: recent findings in the diagnosis and treatment of disturbed sleep. New Engl J Med 290 (1974) 487
64. Zarcone V. Narcolepsy. New Engl J Med 288 (1973) 1156-1166
65. Pollak C.P., and Green J. Eating and its relationships with subjective alertness and sleep in narcoleptic subjects living without temporal cues. Sleep 13 (1990) 467-478
66. Honda Y., Doi Y., Ninomiya C., et al. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep 9 (1986) 254-259
67. Schuld A., Hebebrand J., Geller F., et al. Increased body-mass index in patients with narcolepsy. Lancet 355 (2000) 1274-1275
68. Lammers G.J., Pijl H., Iestra J., et al. Spontaneous food choice in narcolepsy. Sleep 19 (1996) 75-76
69. Middlekoop H.A., Lammers G.J., Van Hilten B.J., et al. Circadian distribution of motor activity and immobility in narcolepsy: assessment with continuous motor activity monitoring. Psychophysiology 32 (1995) 286-291
70. Overeem S., Mignot E., van Dijk J.G., et al. Narcolepsy: clinical features, new pathophysiological insights, and future perspectives. J Clin Neurophysiol 18 (2001) 78-105
71. Daniels E., King M.A., Smith I.E., et al. Health-related quality of life in narcolepsy. J Sleep Res 10 (2001) 75
72. Cohen F.L., Nehring W.M., and Cloninger L. Symptom description and management in narcolepsy. Holist Nurs Pract 10 (1996) 45-53
73. Alaia S.L. Life effects of narcolepsy: measures of negative impact, social support and psychological well-being. Loss, grief, and care 5 (1992) 1-22
74. Broughton R., and Mamelak M. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci 6 (1979)
75. Lammers G.J., Arends J., Declerck A.C., et al. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep 16 (1993) 216-220
76. Mamelak M., Escriu J.M., and Stokan O. The effects of gamma-hydroxybutrate on sleep. Biol Psychiatry 12 (1977) 273-288
77. Scrima L., Hartman P.G., Johnson Jr. F.H., et al. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy; double blind subjective measures. Biol Psychiatry 26 (1989) 331-343
78. Scrima L., Hartman P.G., Johnson Jr. F.H., et al. The effects of gamma-hydroxybutyrate on the sleep of patients with narcolepsy: a double blind study. Sleep 13 (1990) 479-490
79. The US Xyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for treatment of narcolepsy. Sleep 25 (2002) 43-49
80. Broughton R., and Mamelak M. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy. Can J Neurol Sci 7 (1980) 23-31
81. Scharf M.B., Brown D., Woods M., et al. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 46 (1985) 222-225
82. Rogers A.E., Aldrich M.S., Berrios A.M., et al. Compliance with stimulant medications in narcolepsy. Sleep 20 (1997) 28-33
83. Rogers A.E., Cantor C., and Marcus S. Compliance with stimulant medications in patients with narcolepsy: measurement with a MEMS TrackCap. [abstract]. Sleep 24 Suppl (2001)
84. Firestone P. Factors associated with children's adherence to stimulant medication. Am J Orthopsychiat 52 (1982) 447-457
85. Kauffman R.E., Smith-Wright D., Reese C.A., et al. Medication compliance in hyperactive children. Pediatr Pharmacol (New York) 1 (1981) 231-237
86. Simons M.R. Nursing interventions related to compliance. Nurs Clin North Am 27 (1992) 477-485
87. Sleator E.K. Measurement of compliance. Psychopharmacol Bull 21 (1985) 1089-1093
88. Cramer J.A., Mattson R.H., Prevey M.L., et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 261 (1989) 3273-3277
89. Urquhart J. Variable patient compliance in ambulatory trials-nuisance, threat, opportunity. J Antimicrob Chemother 32 (1993) 643-649
90. The working group on health education and high blood pressure control. The physician's guide; improving adherence among hypertensive patients (1987), US Department of Health and Human Services, Public Health Service, National Institute of Health, Washington, DC
91. Ward G.W. How misconceptions deter maintenance. Urban Health 6 (1977) 28-29
92. MacLeod V., and Shneerson J. Narcolepsy: nursing the sleeping sickness. Nurs Times 94 (1998) 48-50
93. Stansberry T.T. Narcolepsy: unveiling a mystery. Am J Nurs 101 (2001) 50-53